KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Assets Average (2019 - 2025)

Moderna (MRNA) has disclosed Assets Average for 5 consecutive years, with $13.4 billion as the latest value for Q1 2025.

  • On a quarterly basis, Assets Average changed N/A to $13.4 billion in Q1 2025 year-over-year; TTM through Mar 2025 was $13.4 billion, a N/A change, with the full-year FY2022 number at $25.3 billion, up 57.87% from a year prior.
  • Assets Average was $13.4 billion for Q1 2025 at Moderna, down from $26.1 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $26.1 billion in Q1 2022 to a low of $10.0 billion in Q1 2021.
  • A 3-year average of $17.6 billion and a median of $16.5 billion in 2021 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: surged 447.75% in 2021, then skyrocketed 160.99% in 2022.
  • Moderna's Assets Average stood at $22.8 billion in 2021, then increased by 14.66% to $26.1 billion in 2022, then plummeted by 48.65% to $13.4 billion in 2025.
  • Per Business Quant, the three most recent readings for MRNA's Assets Average are $13.4 billion (Q1 2025), $26.1 billion (Q1 2022), and $22.8 billion (Q4 2021).